Literature DB >> 2584407

Immunolocalization of alpha interferon in liver disease.

C G Sutherland1, A M al-Badri, A G Howatson, M A Farquharson, A K Foulis.   

Abstract

The expression of immunoreactive alpha interferon was examined in 78 liver biopsy specimens using an indirect immunoperoxidase technique. Biopsy specimens included cases of acute viral hepatitis, chronic active hepatitis, primary biliary cirrhosis, alcoholic hepatitis, large bile duct obstruction and normal liver. Kupffer cells were positive for alpha interferon in all cases. Hepatocytes were negative for alpha interferon in normal liver but in acute viral hepatitis were positive in perivenular and necrotic areas. Hepatocytes were positive in periportal areas, associated with piecemeal necrosis, in chronic active hepatitis and primary biliary cirrhosis, and were positive in perivenular areas in alcoholic hepatitis and large bile duct obstruction. The unexpected finding of alpha interferon in hepatocytes in non-viral liver disease indicates that the presence of this substance in liver cells cannot be taken as a specific marker of viral infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584407      PMCID: PMC501865          DOI: 10.1136/jcp.42.10.1065

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  The distribution of immunoreactive interferon-alpha in normal human tissues.

Authors:  N U Khan; K A Pulford; M A Farquharson; A Howatson; C Stewart; R Jackson; A M McNicol; A K Foulis
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

Review 2.  Interferons and their actions.

Authors:  S Pestka; J A Langer; K C Zoon; C E Samuel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Interferon system in acute viral hepatitis.

Authors:  S Levin; T Hahn
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

4.  Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue.

Authors:  A R Jilbert; C J Burrell; E J Gowans; P J Hertzog; A W Linnane; B P Marmion
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

5.  Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis.

Authors:  Y Nagafuchi; P J Scheuer
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

6.  Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.

Authors:  A K Foulis; M A Farquharson; A Meager
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

7.  A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.

Authors:  T Exley; S Parti; S Barwick; A Meager
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

  7 in total
  1 in total

1.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.